At Enterra Medical, we believe in restoring more than just physical symptoms - we believe in giving people their lives back. Our team is singularly focused on helping patients with chronic gastroparesis find relief through the Enterra® Therapy system, a groundbreaking gastric electrical stimulation approach. We were founded in 2022 with a specific mission: to advance technology, expand clinical science, and accelerate access to this life-changing therapy. With over 15,000 patients already treated, we know our work makes a tangible difference in people's daily lives.
Our culture is defined by relentless dedication to patient outcomes and scientific rigor. Originally developed by Medtronic and FDA-approved in 2000, Enterra Therapy is now in the hands of a team that lives and breathes gastroparesis treatment. We collaborate closely with healthcare providers, from implanting surgeons to referring gastroenterologists, ensuring every patient receives comprehensive support throughout their journey. Our engineers and medical professionals work together to continuously improve our implantable neurostimulation technology, which delivers mild electrical pulses to reduce nausea and vomiting. We are not just manufacturing devices - we are providing hope for patients who have exhausted other treatment options.
